10X Genomics Stock Forecast - Period Momentum Indicator

TXG Stock  USD 15.30  0.99  6.92%   
10X Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of 10X Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At this time, 10X Genomics' Asset Turnover is most likely to slightly decrease in the upcoming years. . The current Common Stock Shares Outstanding is estimated to decrease to about 85.8 M. The current Net Loss is estimated to decrease to about (156.9 M).
10X Genomics has current Period Momentum Indicator of 0.99. Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check 10X Genomics VolatilityBacktest 10X GenomicsInformation Ratio  

10X Genomics Trading Date Momentum

On November 25 2024 10X Genomics was traded for  15.30  at the closing time. Highest 10X Genomics's price during the trading hours was 15.67  and the lowest price during the day was  14.61 . The net volume was 2.4 M. The overall trading history on the 25th of November had no effect on price fluctuation. The daily price change to current price is 3.92% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare 10X Genomics to competition

Other Forecasting Options for 10X Genomics

For every potential investor in 10X, whether a beginner or expert, 10X Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. 10X Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in 10X. Basic forecasting techniques help filter out the noise by identifying 10X Genomics' price trends.

10X Genomics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X Genomics stock to make a market-neutral strategy. Peer analysis of 10X Genomics could also be used in its relative valuation, which is a method of valuing 10X Genomics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

10X Genomics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of 10X Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of 10X Genomics' current price.

10X Genomics Market Strength Events

Market strength indicators help investors to evaluate how 10X Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 10X Genomics shares will generate the highest return on investment. By undertsting and applying 10X Genomics stock market strength indicators, traders can identify 10X Genomics entry and exit signals to maximize returns.

10X Genomics Risk Indicators

The analysis of 10X Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in 10X Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting 10x stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether 10X Genomics is a strong investment it is important to analyze 10X Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 10X Genomics' future performance. For an informed investment choice regarding 10X Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of 10X Genomics to cross-verify your projections.
For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.52)
Revenue Per Share
5.261
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
Return On Equity
(0.25)
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.